Know Cancer

or
forgot password

C-Reactive Protein As a Predictor of Major Transplant Complications in Pediatric Stem Cell Transplant Patients


Phase 2/Phase 3
6 Months
20 Years
Not Enrolling
Both
Cancer, Leukemia, Stem Cell Transplantation

Thank you

Trial Information

C-Reactive Protein As a Predictor of Major Transplant Complications in Pediatric Stem Cell Transplant Patients


Inclusion Criteria:



- Age 6 months to 20 years

- Patient undergoing a stem cell transplant (allogeneic, syngeneic, or autologous) at
Childrens' Memorial Hospital

- IRB approved informed consent (and assent for children age 12-17)

Type of Study:

Observational

Study Design:

Observational Model: Case-Only, Time Perspective: Prospective

Outcome Measure:

To determine whether quantitative c-reactive protein measurements can predict major morbidity and mortality in pediatric stem cell transplant patients.

Outcome Time Frame:

To day +100 post transplant

Safety Issue:

No

Principal Investigator

Morris Kletzel, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Ann & Robert H Lurie Children's Hospital of Chicago

Authority:

United States: Institutional Review Board

Study ID:

SCT 0403 CRP

NCT ID:

NCT00179868

Start Date:

January 2003

Completion Date:

February 2008

Related Keywords:

  • Cancer
  • Leukemia
  • Stem Cell Transplantation
  • cancer
  • leukemia
  • stem cell transplant
  • complications
  • Leukemia

Name

Location
Children's Memorial Hospital Chicago, Illinois  60614